Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000009:adverse effects; D004334:Drug Administration Schedule; D004487:Edema / Q000139:chemically induced; D004890:Erythema / Q000139:chemically induced*; D005472:Fluorouracil / Q000009:adverse effects; D005534:Foot Diseases / Q000139:chemically induced*; D006225:Hand / Q000187:drug effects*; D006801:Humans; D007263:Infusions, Parenteral; D010146:Pain / Q000139:chemically induced; D010292:Paresthesia / Q000139:chemically induced*; D013577:Syndrome
D000970:Antineoplastic Agents; D004317:Doxorubicin; D005472:Fluorouracil